Egyptian Drug Authority · Egypt
DEA-EG-2022-0013
Tier 1 · Regulator-publishedUnclassifiedPublic warningStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(13) For 2022
- Date issued
- 11 May 2022
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- Cipralex 10mg
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- Not published with the notice
- Expiry dates
- Not published with the notice
- Action type
- Public warning
- Classification
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- @egyptiandrugauthority
www.edaegypt.gov.eg
15301
١١ مايو ٢٢٠٢
حيـــث أن العبـــوات الأصليـــة لهذا المســـتحضر يمكـــن التفرقة
ظاهرياً بينها وبين العبوات المغشوشة كالآتى:
Cipralex 10mg
H.Lundbeck A/Sتصنيع
إستيراد وتوزيع : شركة مالتى فارما
يتم ضبط وتحريز العبوات المقلدة والمغشوشة من
المستحضر التالي:
منشور
غش تجاري
Cipralex 10mgOriginal language: ar
- Notice text in English
- Trade-counterfeiting circular, May 2022. Counterfeit and adulterated packs of the following product are to be impounded and seized: Cipralex 10mg, manufactured by H. Lundbeck A/S, imported and distributed by Multi Pharma. Genuine packs can be told apart by sight from the adulterated ones as set out in the circular.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 1
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- 84ac89d274a20c8a67ce4f71cc1762bde72c9c4c9b2a210a144a7c1d8ce55e78SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:35:48 UTC
Cite this record
Drug Eye Africa (2022). DEA-EG-2022-0013: Cipralex 10mg — Public warning, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2022/dea-eg-2022-0013Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.